Summary
In the last decade lentiviral gene transfer vectors have gained significant place both in basic science and gene therapy applications. A number of gene transfer applications would benefit from vectors capable of expressing multiple genes. This chapter focuses on production of bicistronic and tricistronic lentiviral vectors based on the internal ribosomal entry site (IRES) sequence of encephalomyocarditis virus (EMCV) and/or foot-and-mouth disease virus (FMDV) cleavage factor 2A. Multigene vectors produced high titer viral particles and were able to simultaneously express two or three transgenes in transduced cells. The level of expression of individual transgenes varied depending on the transgene itself, its position within the construct, the total number of transgenes expressed, the strategy used for multigene expression, and the number of copies of proviral insertions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ngoi, S.M., Chien, A.C. and Lee, C.G. Exploiting internal ribosome entry sites in gene therapy vector design, Curr. Gene Ther., 4: 15–31, 2004.
Mizuguchi, H., Xu, Z., Ishii-Watabe, A., Uchida, E. and Hayakawa, T. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector, Mol. Ther., 1: 376–382, 2000.
Zhou, Y., Aran, J., Gottesman, M.M. and Pastan, I. Co-expression of human adenosine deaminase and multidrug resistance using a bicistronic retroviral vector, Hum. Gene Ther., 9: 287–293, 1998.
Furler, S., Paterna, J.C., Weibel, M. and Bueler, H. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons, Gene Ther., 8: 864–873, 2001.
de Felipe, P., Martin, V., Cortes, M.L., Ryan, M. and Izquierdo, M. Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy, Gene Ther., 6: 198–208, 1999.
Klump, H., Schiedlmeier, B., Vogt, B., Ryan, M., Ostertag, W. and Baum, C. Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy, Gene Ther., 8: 811–817, 2001.
Stripecke, R., Cardoso, A.A., Pepper, K.A., Skelton, D.C., Yu, X.J., Mascarenhas, L., Weinberg, K.I., Nadler, L.M. and Kohn, D.B. Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage-colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses, Blood, 96: 1317–1326, 2000.
Reiser, J., Lai, Z., Zhang, X.Y. and Brady, R.O. Development of multigene and regulated lentivirus vectors, J. Virol., 74: 10589–10599, 2000.
Yu, X., Zhan, X., D’Costa, J., Tanavde, V.M., Ye, Z., Peng, T., Malehorn, M.T., Yang, X., Civin, C.I. and Cheng, L. Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells, Mol. Ther., 7: 827–838, 2003.
Zhu, Y. and Planelles, V. A multigene lentiviral vector system based on differential splicing, Methods Mol. Med., 76: 433–448, 2003.
Chinnasamy, D., Fairbairn, L.J., Neuenfeldt, J., Treisman, J.S., Hanson, J.P., Jr., Margison, G.P. and Chinnasamy, N. Lentivirus-mediated expression of mutant MGMTP140K protects human CD34+ cells against the combined toxicity of O6-benzylguanine and 1,3-bis(2-chloroethyl)-nitrosourea or temozolomide, Hum. Gene Ther., 15: 758–769, 2004.
Chinnasamy, D., Milsom, M.D., Shaffer, J., Neuenfeldt, J., Shaaban, A.F., Margison, G.P., Fairbairn, L.J. and Chinnasamy, N. Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI, Virol. J., 3: 14, 2006.
Zufferey, R., Nagy, D., Mandel, R.J., Naldini, L. and Trono, D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo, Nat. Biotechnol., 15: 871–875, 1997.
Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F.H., Verma, I.M. and Trono, D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector, Science, 272: 263–267, 1996.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Chinnasamy, N., Shaffer, J., Chinnasamy, D. (2009). Production of Multicistronic HIV-1 Based Lentiviral Vectors. In: Hicks, B.W. (eds) Viral Applications of Green Fluorescent Protein. Methods in Molecular Biology™, vol 515. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-559-6_9
Download citation
DOI: https://doi.org/10.1007/978-1-59745-559-6_9
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-934115-87-9
Online ISBN: 978-1-59745-559-6
eBook Packages: Springer Protocols